- Business
- Bowen Acquisition Corp is a Cayman Islands exempted blank check company formed for the purpose of effecting mergers, share exchanges, asset acquisitions, stock purchases, recapitalizations, reorganizations, or similar business combinations with one or more businesses or entities. The company primarily focuses on identifying prospective target businesses with an initial geographic emphasis on Asia, although it does not restrict itself to any specific industry or region. Bowen Acquisition Corp does not produce or sell products directly but engages in acquiring and merging with target companies to facilitate market entry and growth. Its latest major development includes entering into a merger agreement with Shenzhen Qianzhi BioTechnology Co., Ltd., a China-based health and wellness biotech firm specializing in the development, manufacturing, and sales of ozonated health and wellness products such as antibacterial, skincare, gynecological, and andrological applications. This business combination aims to expand Bowen’s portfolio by integrating Qianzhi BioTech’s proprietary ozonated disinfectants and plant-based formulations, which are considered safer and more environmentally friendly alternatives to traditional disinfectants. Bowen Acquisition Corp completed a $60 million initial public offering in mid-2023 to support its strategic initiatives and recently amended and extended the merger agreement with Qianzhi BioTech into late 2025. Headquartered in New York, the company operates within the dynamic special purpose acquisition company (SPAC) sector, leveraging strategic partnerships and acquisitions to create shareholder value through business combinations primarily focused on the Asian market.